Clinical Trial Update: Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether oral pantoprazole is as effective as intravenous pantoprazole for preventing rebleeding in patients with high-risk b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Peptic Ulcers | Phase 3 | Status: UNKNOWN